Brain Interchange ONE SR—the implantable neuromodulation technology for stroke r...
Brain Interchange ONE SR—the implantable neuromodulation technology for stroke rehabilitation
Electrical brain stimulation has been successfully used since the 1990s to treat neurological illnesses, particularly movement disorders.
Most of the devices for this novel approach are based on the old pacemaker technology. Comp...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
SAF2008-03694
NUEVOS DISPOSITIVOS DE REHABILITACION VISUAL
121K€
Cerrado
BFORE
Breakthrough Brain Stimulation Device for Epilepsy
4M€
Cerrado
DENECOR
Devices for Neurocontrol and Neurorehabilitation
20M€
Cerrado
PID2019-110410RB-I00
IMPLANTE MILIMETRICO CON INTELIGENCIA ARTIFICIAL INTEGRADA P...
138K€
Cerrado
NEMESIS
NEurological MEchanismS of Injury, and Sleep-like cellular...
10M€
Cerrado
EMUNITI
Epilepsy Treatment Using Neuromodulation by Non-Invasive Tem...
2M€
Cerrado
Información proyecto BIC ONE
Duración del proyecto: 18 meses
Fecha Inicio: 2023-04-06
Fecha Fin: 2024-10-31
Líder del proyecto
CORTEC GMBH
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
4M€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Electrical brain stimulation has been successfully used since the 1990s to treat neurological illnesses, particularly movement disorders.
Most of the devices for this novel approach are based on the old pacemaker technology. Companies are unwilling to take device development risks & rely on established tech, limiting new therapy developments. Many neurological diseases are still treated with pharmaceuticals only, which has limited effectiveness and causes severe side effects. Neuromodulation—electrical stimulation research has increased in recent decades. Additional recording capabilities & closed loop therapy expand therapeutic options.
CorTec aims to provide novel implantable tech to overcome the current limitations: it enables researchers, medical institutions & industry to develop new therapies & devices. We plan to finalise the development of our tech for stroke rehabilitation, conduct clinical trials & get market approval in 2029, generating €250M in sales in 2030.